Amylin cfDNA levels were increased at the time of disease onset and persisted in diabetic NOD mice, prompting us to test whether methylation-specific human amylin primers can detect amylin cfDNA in plasma samples from RO T1D patients and age-matched unrelated HC collected at the Children’s Hospital of Wisconsin. The gene discussed is IAPP; the disease is type 1 diabetes mellitus.